- Teva, Mylan launch Viagra generics in Europe
- Federal government must find alternatives to rescheduling hydrocodone combination drugs
- New cholesterol, obesity guidelines give greater role to statins, call for more research into weight-loss drugs
- FDA gives tentative approval to Mylan's generic Crestor
- CVS Caremark study: More education needed on genetic testing in prescribing antiplatelet drugs
PITTSBURGH — Mylan has launched a generic drug for treating cholesterol problems, the company said Monday.
Mylan announced the launch of generic fenofibric acid delayed-release capsules in the 45-mg and 135-mg strengths.
The drug is a generic version of Abbott's Trilipix, designed for use in combination with statin drugs and diet to reduce triglycerides and increase high-density lipoprotein or "good" cholesterol.
Various versions of the drug had sales of about $553.6 million during the 12-month period that ended in March, according to IMS Health.